122 related articles for article (PubMed ID: 18686)
1. On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.
Björkman S; Sievertsson H
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):79-81. PubMed ID: 18686
[TBL] [Abstract][Full Text] [Related]
2. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
Björkman S; Castensson S; Sievertsson H
J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
[TBL] [Abstract][Full Text] [Related]
3. Peptides related to melanostatin (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
Björkman S; Castensson S; Lindeke B; Sievertsson H
Acta Pharm Suec; 1976; 13(4):289-98. PubMed ID: 11638
[No Abstract] [Full Text] [Related]
4. MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
Björkman S; Lewander T; Zetterström T
J Pharm Pharmacol; 1980 Apr; 32(4):296-7. PubMed ID: 6103063
[No Abstract] [Full Text] [Related]
5. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
Hara C; Kastin AJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
[TBL] [Abstract][Full Text] [Related]
7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
8. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
[TBL] [Abstract][Full Text] [Related]
9. Effects of Pro-Leu-Gly-NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine.
Slater P; Dickinson SL
J Pharm Pharmacol; 1982 Feb; 34(2):113-5. PubMed ID: 6121869
[No Abstract] [Full Text] [Related]
10. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
Mycroft FJ; Wei ET
Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
[TBL] [Abstract][Full Text] [Related]
11. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
[TBL] [Abstract][Full Text] [Related]
12. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
Kastin AJ; Miller LG; Schwartzenburg DS
Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
Mycroft FJ; Bhargava HN; Wei ET
Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of Pro-Leu-Gly NH2 and L-leucine on tremorine-induced tremor and rigidity in rats.
Dickinson SL; Slater P
J Pharm Pharmacol; 1982 May; 34(5):336-7. PubMed ID: 6123577
[No Abstract] [Full Text] [Related]
15. Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat.
Bhargava HN; Ramarao P
Peptides; 1989; 10(4):767-71. PubMed ID: 2573893
[TBL] [Abstract][Full Text] [Related]
16. Some observations on the pharmacological activity of MIF (Pro-Leu-Gly-NH2).
Turnbull MJ; Wheeler H
J Pharm Pharmacol; 1980 Nov; 32(11):803-4. PubMed ID: 6110739
[No Abstract] [Full Text] [Related]
17. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
Vivas A; Celis ME
Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
[TBL] [Abstract][Full Text] [Related]
18. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
Johnson RL; Rajakumar G; Yu KL; Mishra RK
J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and conformational study of two L-prolyl-L-leucyl-glycinamide analogues with a reduced peptide bond.
Vander Elst P; Elseviers M; De Cock E; Van Marsenille M; Tourwé D; Van Binst G
Int J Pept Protein Res; 1986 Jun; 27(6):633-42. PubMed ID: 2875969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
